Understanding Drug Sensitivity and Tackling Resistance in Cancer

Academic Article


  • Decades of research into the molecular mechanisms of cancer and the development of novel therapeutics have yielded a number of remarkable successes. However, our ability to broadly assign effective, rationally targeted therapies in a personalized manner remains elusive for many patients, and drug resistance persists as a major problem. This is in part due to the welldocumented heterogeneity of cancer, including the diversity of tumor cell lineages and cell states, the spectrum of somatic mutations, the complexity of microenvironments, and immunesuppressive features and immune repertoires, which collectively require numerous different therapeutic approaches. Here, we describe a framework to understand the types and biological causes of resistance, providing translational opportunities to tackle drug resistance by rational therapeutic strategies.
  • Published In

  • Cancer Research  Journal
  • Digital Object Identifier (doi)

    Author List

  • Tyner JW; Haderk F; Kumaraswamy A; Baughn LB; Van Ness B; Liu S; Marathe H; Alumkal JJ; Bivona TG; Chan KS
  • Start Page

  • 1448
  • End Page

  • 1460
  • Volume

  • 82
  • Issue

  • 8